Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.

作者: Furio Pacini , Fulvio Basolo , Rossella Elisei , Laura Fugazzola , Arianna Cola

DOI: 10.1093/AJCP/95.3.300

关键词: MedicineImmunohistochemistryRadioimmunoassayPathologySurvival rateCalcitoninCarcinoembryonic antigenCalcitonin gene-related peptideMedullary thyroid cancerThyroglobulin

摘要: The authors investigated the humoral and tissue expression of six antigens associated with medullary thyroid cancer (MTC): calcitonin (CT), gene-related peptide (CGRP), carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), somatostatin (SRIF), thyroglobulin (TG). were studied in neoplastic C cells using immunohistochemistry specific antisera plasma radioimmunoassay. Eighteen patients (8 male 10 female patients, aged 12-72 years) studied. Mean follow-up was 70.7 months (range, 2-179 months). Nine (50%) died their disease after a mean 47.2 2-116 By immunostaining, primary tumors expressed CT CEA all cases NSE positive 90%, CGRP 66%, SRIF 63%, TG 58%. Metastatic tissues staining, 92.8% CEA, 71.4% NSE, 73.3% CGRP, 38.5% SRIF, only 13.3% staining. In percentage degree staining variable among different antigens. an hypersecretion corresponding circulation case CEA. levels these elevated metastases could accurately predict appearance new or indicate effective treatment previous by surgery. few had increased concentrations usually occurred during very advanced phases disease. Detectable serum never observed. When outcome compared CT, TG, no correlation be found. On contrary, tumor differentiate two groups survival rates. SRIF-positive rates 100% 50% at five seven years, respectively, whereas SRIF-negative 40% years 25% years.

参考文章(32)
Rapid reversal of carcinoid crisis with a somatostatin analogue. The New England Journal of Medicine. ,vol. 313, pp. 1229- 1230 ,(1985) , 10.1056/NEJM198511073131915
D.Harold Copp, Hormonal control of hypercalcemia. Historic development of the calcitonin concept. The American Journal of Medicine. ,vol. 43, pp. 648- 655 ,(1967) , 10.1016/0002-9343(67)90105-2
Richard F. Carter, Khalil N. Bitar, Alvin M. Zfass, Gabriel M. Makhlouf, Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat. Gastroenterology. ,vol. 74, pp. 726- 730 ,(1978) , 10.1016/0016-5085(78)90252-4
Hazard Jb, The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review. American Journal of Pathology. ,vol. 88, pp. 213- 250 ,(1977)
F. Pacini, A. Pinchera, C. Giani, L. Grasso, F. Doveri, L. Baschieri, Serum thyroglobulin in thyroid carcinoma and other thyroid disorders Journal of Endocrinological Investigation. ,vol. 3, pp. 283- 292 ,(1980) , 10.1007/BF03348277
Marleney Uribe, Margaret Grimes, Cecilia M. Fenoglio-Preiser, Carl Feind, Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. The American Journal of Surgical Pathology. ,vol. 9, pp. 577- 594 ,(1985) , 10.1097/00000478-198508000-00003
S. SCHIFTER, E. D. WILLIAMS, R. K. CRAIG, H. H. HANSEN, CALCITONIN GENE‐RELATED PEPTIDE AND CALCITONIN IN MEDULLARY THYROID CARCINOMA Clinical Endocrinology. ,vol. 25, pp. 703- 710 ,(1986) , 10.1111/J.1365-2265.1986.TB03626.X
D. J. Koerker, W. Ruch, E. Chideckel, J. Palmer, C. J. Goodner, J. Ensinck, C. C. Gale, Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas Science. ,vol. 184, pp. 482- 484 ,(1974) , 10.1126/SCIENCE.184.4135.482